IL17A and urinary bladder carcinoma: Apart of blood vessels, increased immunoreactivity for CD90+ fibroblasts was observed in bladder cancer, suggesting that these fibroblasts might also contribute to expression of IL-17 family ligands and receptors and possibly to pathogenesis of bladder cancer, through enhancing tumor growth [28, 29].